In fact CTC enumeration and CXCR4 expression are promising prognostic biomarkers for CTCs in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) at baseline and post-treatment62. This evidence concerns the gene CXCR4 and small cell lung carcinoma.